Sophie Megnien

Company: Summit Clinical Research

Job title: Chief Medical Officer


Chair’s Closing Remarks 3:00 pm

Read more

day: Day 1 Seminar B Post-Lunch Tracks

Panel Discussion: Navigating the Evolving NASH Landscape to Apprehend the Future of Combination Therapies & Optimize Treatment 2:30 pm

Deliberating the best approaches to position GLP-1s for different indications, mono therapy, and combination therapy How are we maximizing the use of injectables and oral medicines? Uniting towards a shared goal to advances towards efficacious NASH treatments through collaborative effortsRead more

day: Day 1 Seminar B Post-Lunch Tracks

Exploring the Next Generation of Combination Therapies & Assessing Their Safety in Clinical Trials
Track Moderators:
10:59 am

Read more

day: Day 1 Seminar B Pre-Lunch Tracks

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.